questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Hydrolases
Glycosidases
Glucosidases
Cellulases
Glucan endo-1,3-beta-glucosidase
Glucan endo-1,3-beta-glucosidase : Questions médicales fréquentes
Diagnostic
5
Déficience enzymatique
Tests génétiques
Tests biochimiques
Échantillons biologiques
Troubles digestifs
Malabsorption
Marqueurs biologiques
Glucanes
Tests génétiques
Mutations
Symptômes
5
Douleurs abdominales
Diarrhée
Retard de croissance
Troubles digestifs
Éruptions cutanées
Malabsorption
Variabilité des symptômes
Individus
Prévention
5
Prévention
Diagnostic précoce
Dépistage
Tests génétiques
Régime alimentaire
Qualité de vie
Conseils diététiques
Gestion de la condition
Traitements
5
Régime alimentaire
Glucanes
Suppléments enzymatiques
Digestion
Thérapie génique
Recherche
Médicaments antidiarrhéiques
Probiotiques
Changements de mode de vie
Suivi médical
Complications
5
Complications digestives
Infections
Malnutrition
Absorption des nutriments
Complications chroniques
Développement
Troubles psychologiques
Malnutrition
Suivi médical
Gestion des symptômes
Facteurs de risque
5
Antécédents familiaux
Conditions génétiques
Alimentation
Glucanes complexes
Infections intestinales
Symptômes
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Glucan endo-1,3-beta-glucosidase : Questions médicales les plus fréquentes",
"headline": "Glucan endo-1,3-beta-glucosidase : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Glucan endo-1,3-beta-glucosidase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-10",
"dateModified": "2026-07-29",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Glucan endo-1,3-beta-glucosidase"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Cellulases",
"url": "https://questionsmedicales.fr/mesh/D044602",
"about": {
"@type": "MedicalCondition",
"name": "Cellulases",
"code": {
"@type": "MedicalCode",
"code": "D044602",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.450.420.200"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Glucan endo-1,3-beta-glucosidase",
"alternateName": "Glucan Endo-1,3-beta-D-Glucosidase",
"code": {
"@type": "MedicalCode",
"code": "D004693",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Vasileios Bampidis",
"url": "https://questionsmedicales.fr/author/Vasileios%20Bampidis",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Giovanna Azimonti",
"url": "https://questionsmedicales.fr/author/Giovanna%20Azimonti",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Maria de Lourdes Bastos",
"url": "https://questionsmedicales.fr/author/Maria%20de%20Lourdes%20Bastos",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Henrik Christensen",
"url": "https://questionsmedicales.fr/author/Henrik%20Christensen",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with",
"datePublished": "2024-05-15",
"url": "https://questionsmedicales.fr/article/38751505",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2903/j.efsa.2024.8795"
}
},
{
"@type": "ScholarlyArticle",
"name": "Lower (1,3)-beta-d-glucan (BDG) sensitivity and in-vitro levels in Candida auris and Candida parapsilosis strains.",
"datePublished": "2024-02-29",
"url": "https://questionsmedicales.fr/article/38431255",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cmi.2024.02.012"
}
},
{
"@type": "ScholarlyArticle",
"name": "Molecular mechanism for endo-type action of glycoside hydrolase family 55 endo-β-1,3-glucanase on β1-3/1-6-glucan.",
"datePublished": "2023-09-27",
"url": "https://questionsmedicales.fr/article/37774972",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jbc.2023.105294"
}
},
{
"@type": "ScholarlyArticle",
"name": "Novel, cold-adapted D-laminaribiose- and D-glucose-releasing GH16 endo-β-1,3-glucanase from",
"datePublished": "2024-10-02",
"url": "https://questionsmedicales.fr/article/39417081",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fmicb.2024.1470106"
}
},
{
"@type": "ScholarlyArticle",
"name": "Halapricum hydrolyticum sp. nov., a beta-1,3-glucan utilizing haloarchaeon from hypersaline lakes.",
"datePublished": "2023-10-07",
"url": "https://questionsmedicales.fr/article/37826928",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.syapm.2023.126471"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrolases",
"item": "https://questionsmedicales.fr/mesh/D006867"
},
{
"@type": "ListItem",
"position": 5,
"name": "Glycosidases",
"item": "https://questionsmedicales.fr/mesh/D006026"
},
{
"@type": "ListItem",
"position": 6,
"name": "Glucosidases",
"item": "https://questionsmedicales.fr/mesh/D005959"
},
{
"@type": "ListItem",
"position": 7,
"name": "Cellulases",
"item": "https://questionsmedicales.fr/mesh/D044602"
},
{
"@type": "ListItem",
"position": 8,
"name": "Glucan endo-1,3-beta-glucosidase",
"item": "https://questionsmedicales.fr/mesh/D004693"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Glucan endo-1,3-beta-glucosidase - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Glucan endo-1,3-beta-glucosidase",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-09-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Glucan endo-1,3-beta-glucosidase",
"description": "Comment diagnostiquer une déficience en glucan endo-1,3-beta-glucosidase ?\nQuels tests sont utilisés pour évaluer l'activité de l'enzyme ?\nQuels symptômes peuvent indiquer un problème avec cette enzyme ?\nY a-t-il des marqueurs biologiques associés à cette enzyme ?\nComment les tests génétiques aident-ils au diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D004693#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Glucan endo-1,3-beta-glucosidase",
"description": "Quels sont les symptômes d'une déficience en glucan endo-1,3-beta-glucosidase ?\nLa fatigue est-elle un symptôme associé ?\nLes enfants peuvent-ils présenter des symptômes ?\nY a-t-il des symptômes cutanés associés ?\nLes symptômes varient-ils d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D004693#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Glucan endo-1,3-beta-glucosidase",
"description": "Peut-on prévenir les déficiences enzymatiques ?\nY a-t-il des tests de dépistage recommandés ?\nComment un régime alimentaire peut-il aider ?\nLes conseils diététiques sont-ils importants ?\nLes vaccinations sont-elles nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D004693#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Glucan endo-1,3-beta-glucosidase",
"description": "Quels traitements sont disponibles pour cette déficience ?\nDes suppléments peuvent-ils aider ?\nLa thérapie génique est-elle une option ?\nComment gérer les symptômes digestifs ?\nLes changements de mode de vie sont-ils recommandés ?",
"url": "https://questionsmedicales.fr/mesh/D004693#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Glucan endo-1,3-beta-glucosidase",
"description": "Quelles complications peuvent survenir ?\nLa malnutrition est-elle une complication possible ?\nDes complications à long terme sont-elles possibles ?\nLes troubles psychologiques peuvent-ils être liés ?\nComment prévenir les complications ?",
"url": "https://questionsmedicales.fr/mesh/D004693#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Glucan endo-1,3-beta-glucosidase",
"description": "Quels sont les facteurs de risque pour cette déficience ?\nL'alimentation joue-t-elle un rôle ?\nLes infections intestinales sont-elles un facteur de risque ?\nLe stress peut-il influencer la condition ?\nLes médicaments peuvent-ils être un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D004693#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en glucan endo-1,3-beta-glucosidase ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques et des analyses génétiques peuvent confirmer la déficience."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité de l'enzyme ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests biochimiques mesurant l'activité enzymatique dans des échantillons biologiques sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème avec cette enzyme ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles digestifs, des douleurs abdominales et des malabsorptions peuvent survenir."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs biologiques associés à cette enzyme ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux de glucanes dans le sang peuvent être un indicateur."
}
},
{
"@type": "Question",
"name": "Comment les tests génétiques aident-ils au diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils identifient des mutations spécifiques dans le gène codant pour l'enzyme."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une déficience en glucan endo-1,3-beta-glucosidase ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs abdominales, des ballonnements et des diarrhées."
}
},
{
"@type": "Question",
"name": "La fatigue est-elle un symptôme associé ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fatigue peut résulter d'une malabsorption des nutriments due à la déficience."
}
},
{
"@type": "Question",
"name": "Les enfants peuvent-ils présenter des symptômes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent avoir des retards de croissance et des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées peuvent survenir en raison de malabsorptions nutritionnelles."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier selon les individus."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les déficiences enzymatiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines déficiences peuvent être évitées par un diagnostic précoce et une gestion appropriée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des tests de dépistage recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de dépistage génétique peuvent être recommandés pour les familles à risque."
}
},
{
"@type": "Question",
"name": "Comment un régime alimentaire peut-il aider ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un régime pauvre en glucanes complexes peut réduire les symptômes et améliorer la qualité de vie."
}
},
{
"@type": "Question",
"name": "Les conseils diététiques sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conseils diététiques personnalisés peuvent aider à gérer la condition."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles nécessaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations ne sont pas directement liées à cette déficience, mais restent importantes."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour cette déficience ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est un régime alimentaire adapté pour éviter les glucanes complexes."
}
},
{
"@type": "Question",
"name": "Des suppléments peuvent-ils aider ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments enzymatiques peuvent être envisagés pour améliorer la digestion."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, la thérapie génique est en recherche, mais pas encore disponible cliniquement."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes digestifs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments antidiarrhéiques et des probiotiques peuvent aider à gérer les symptômes."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie sont-ils recommandés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des modifications alimentaires et un suivi médical régulier sont conseillés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications digestives graves, comme des infections, peuvent survenir en cas de malabsorption."
}
},
{
"@type": "Question",
"name": "La malnutrition est-elle une complication possible ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la malnutrition peut résulter d'une absorption inadéquate des nutriments."
}
},
{
"@type": "Question",
"name": "Des complications à long terme sont-elles possibles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications chroniques peuvent affecter la croissance et le développement."
}
},
{
"@type": "Question",
"name": "Les troubles psychologiques peuvent-ils être liés ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles psychologiques peuvent survenir en raison de la malnutrition et des symptômes."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et une gestion appropriée des symptômes peuvent prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour cette déficience ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux et certaines conditions génétiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en glucanes complexes peut exacerber les symptômes."
}
},
{
"@type": "Question",
"name": "Les infections intestinales sont-elles un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections peuvent aggraver les symptômes chez les personnes déjà affectées."
}
},
{
"@type": "Question",
"name": "Le stress peut-il influencer la condition ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut aggraver les symptômes digestifs et affecter la qualité de vie."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils être un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments peuvent interférer avec la digestion et exacerber les symptômes."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 29/07/2026
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Publications dans "Glucan endo-1,3-beta-glucosidase" :
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase, endo-1,3(4)-beta-glucanase and endo-1,4-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-06-09
Efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2024-05-15
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2022-05-09
Safety and efficacy of a feed additive consisting of endo-1,3(4)-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-01-11
Safety and efficacy of a feed additive consisting of endo-1,4-beta xylanase, endo-1,4-beta-glucanase and xyloglucan-specific-endo-beta-1,4-glucanase produced by
EFSA journal. European Food Safety Authority
2022-12-19
5 publications dans cette catégorie
Publications dans "Glucan endo-1,3-beta-glucosidase" :
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase, endo-1,3(4)-beta-glucanase and endo-1,4-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-06-09
Efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2024-05-15
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2022-05-09
Safety and efficacy of a feed additive consisting of endo-1,3(4)-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-01-11
Safety and efficacy of a feed additive consisting of endo-1,4-beta xylanase, endo-1,4-beta-glucanase and xyloglucan-specific-endo-beta-1,4-glucanase produced by
EFSA journal. European Food Safety Authority
2022-12-19
5 publications dans cette catégorie
Publications dans "Glucan endo-1,3-beta-glucosidase" :
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase, endo-1,3(4)-beta-glucanase and endo-1,4-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-06-09
Efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2024-05-15
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2022-05-09
Safety and efficacy of a feed additive consisting of endo-1,3(4)-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-01-11
Safety and efficacy of a feed additive consisting of endo-1,4-beta xylanase, endo-1,4-beta-glucanase and xyloglucan-specific-endo-beta-1,4-glucanase produced by
EFSA journal. European Food Safety Authority
2022-12-19
5 publications dans cette catégorie
Publications dans "Glucan endo-1,3-beta-glucosidase" :
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase, endo-1,3(4)-beta-glucanase and endo-1,4-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-06-09
Efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2024-05-15
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2022-05-09
Safety and efficacy of a feed additive consisting of endo-1,3(4)-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-01-11
Safety and efficacy of a feed additive consisting of endo-1,4-beta xylanase, endo-1,4-beta-glucanase and xyloglucan-specific-endo-beta-1,4-glucanase produced by
EFSA journal. European Food Safety Authority
2022-12-19
5 publications dans cette catégorie
Publications dans "Glucan endo-1,3-beta-glucosidase" :
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase, endo-1,3(4)-beta-glucanase and endo-1,4-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-06-09
Efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2024-05-15
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2022-05-09
Safety and efficacy of a feed additive consisting of endo-1,3(4)-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-01-11
Safety and efficacy of a feed additive consisting of endo-1,4-beta xylanase, endo-1,4-beta-glucanase and xyloglucan-specific-endo-beta-1,4-glucanase produced by
EFSA journal. European Food Safety Authority
2022-12-19
5 publications dans cette catégorie
Publications dans "Glucan endo-1,3-beta-glucosidase" :
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase, endo-1,3(4)-beta-glucanase and endo-1,4-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-06-09
Efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2024-05-15
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2022-05-09
Safety and efficacy of a feed additive consisting of endo-1,3(4)-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-01-11
Safety and efficacy of a feed additive consisting of endo-1,4-beta xylanase, endo-1,4-beta-glucanase and xyloglucan-specific-endo-beta-1,4-glucanase produced by
EFSA journal. European Food Safety Authority
2022-12-19
5 publications dans cette catégorie
Publications dans "Glucan endo-1,3-beta-glucosidase" :
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase, endo-1,3(4)-beta-glucanase and endo-1,4-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-06-09
Efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2024-05-15
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2022-05-09
Safety and efficacy of a feed additive consisting of endo-1,3(4)-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-01-11
Safety and efficacy of a feed additive consisting of endo-1,4-beta xylanase, endo-1,4-beta-glucanase and xyloglucan-specific-endo-beta-1,4-glucanase produced by
EFSA journal. European Food Safety Authority
2022-12-19
5 publications dans cette catégorie
Publications dans "Glucan endo-1,3-beta-glucosidase" :
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase, endo-1,3(4)-beta-glucanase and endo-1,4-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-06-09
Efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2024-05-15
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2022-05-09
Safety and efficacy of a feed additive consisting of endo-1,3(4)-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-01-11
Safety and efficacy of a feed additive consisting of endo-1,4-beta xylanase, endo-1,4-beta-glucanase and xyloglucan-specific-endo-beta-1,4-glucanase produced by
EFSA journal. European Food Safety Authority
2022-12-19
5 publications dans cette catégorie
Publications dans "Glucan endo-1,3-beta-glucosidase" :
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase, endo-1,3(4)-beta-glucanase and endo-1,4-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-06-09
Efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2024-05-15
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2022-05-09
Safety and efficacy of a feed additive consisting of endo-1,3(4)-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-01-11
Safety and efficacy of a feed additive consisting of endo-1,4-beta xylanase, endo-1,4-beta-glucanase and xyloglucan-specific-endo-beta-1,4-glucanase produced by
EFSA journal. European Food Safety Authority
2022-12-19
5 publications dans cette catégorie
Publications dans "Glucan endo-1,3-beta-glucosidase" :
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase, endo-1,3(4)-beta-glucanase and endo-1,4-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-06-09
Efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2024-05-15
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2022-05-09
Safety and efficacy of a feed additive consisting of endo-1,3(4)-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-01-11
Safety and efficacy of a feed additive consisting of endo-1,4-beta xylanase, endo-1,4-beta-glucanase and xyloglucan-specific-endo-beta-1,4-glucanase produced by
EFSA journal. European Food Safety Authority
2022-12-19
5 publications dans cette catégorie
Publications dans "Glucan endo-1,3-beta-glucosidase" :
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase, endo-1,3(4)-beta-glucanase and endo-1,4-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-06-09
Efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2024-05-15
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2022-05-09
Safety and efficacy of a feed additive consisting of endo-1,3(4)-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-01-11
Safety and efficacy of a feed additive consisting of endo-1,4-beta xylanase, endo-1,4-beta-glucanase and xyloglucan-specific-endo-beta-1,4-glucanase produced by
EFSA journal. European Food Safety Authority
2022-12-19
5 publications dans cette catégorie
Publications dans "Glucan endo-1,3-beta-glucosidase" :
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase, endo-1,3(4)-beta-glucanase and endo-1,4-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-06-09
Efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2024-05-15
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2022-05-09
Safety and efficacy of a feed additive consisting of endo-1,3(4)-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-01-11
Safety and efficacy of a feed additive consisting of endo-1,4-beta xylanase, endo-1,4-beta-glucanase and xyloglucan-specific-endo-beta-1,4-glucanase produced by
EFSA journal. European Food Safety Authority
2022-12-19
5 publications dans cette catégorie
Publications dans "Glucan endo-1,3-beta-glucosidase" :
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase, endo-1,3(4)-beta-glucanase and endo-1,4-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-06-09
Efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2024-05-15
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2022-05-09
Safety and efficacy of a feed additive consisting of endo-1,3(4)-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-01-11
Safety and efficacy of a feed additive consisting of endo-1,4-beta xylanase, endo-1,4-beta-glucanase and xyloglucan-specific-endo-beta-1,4-glucanase produced by
EFSA journal. European Food Safety Authority
2022-12-19
5 publications dans cette catégorie
Publications dans "Glucan endo-1,3-beta-glucosidase" :
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase, endo-1,3(4)-beta-glucanase and endo-1,4-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-06-09
Efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2024-05-15
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2022-05-09
Safety and efficacy of a feed additive consisting of endo-1,3(4)-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-01-11
Safety and efficacy of a feed additive consisting of endo-1,4-beta xylanase, endo-1,4-beta-glucanase and xyloglucan-specific-endo-beta-1,4-glucanase produced by
EFSA journal. European Food Safety Authority
2022-12-19
5 publications dans cette catégorie
Publications dans "Glucan endo-1,3-beta-glucosidase" :
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase, endo-1,3(4)-beta-glucanase and endo-1,4-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-06-09
Efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2024-05-15
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2022-05-09
Safety and efficacy of a feed additive consisting of endo-1,3(4)-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-01-11
Safety and efficacy of a feed additive consisting of endo-1,4-beta xylanase, endo-1,4-beta-glucanase and xyloglucan-specific-endo-beta-1,4-glucanase produced by
EFSA journal. European Food Safety Authority
2022-12-19
5 publications dans cette catégorie
Publications dans "Glucan endo-1,3-beta-glucosidase" :
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase, endo-1,3(4)-beta-glucanase and endo-1,4-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-06-09
Efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2024-05-15
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2022-05-09
Safety and efficacy of a feed additive consisting of endo-1,3(4)-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-01-11
Safety and efficacy of a feed additive consisting of endo-1,4-beta xylanase, endo-1,4-beta-glucanase and xyloglucan-specific-endo-beta-1,4-glucanase produced by
EFSA journal. European Food Safety Authority
2022-12-19
5 publications dans cette catégorie
Publications dans "Glucan endo-1,3-beta-glucosidase" :
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase, endo-1,3(4)-beta-glucanase and endo-1,4-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-06-09
Efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2024-05-15
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2022-05-09
Safety and efficacy of a feed additive consisting of endo-1,3(4)-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-01-11
Safety and efficacy of a feed additive consisting of endo-1,4-beta xylanase, endo-1,4-beta-glucanase and xyloglucan-specific-endo-beta-1,4-glucanase produced by
EFSA journal. European Food Safety Authority
2022-12-19
5 publications dans cette catégorie
Publications dans "Glucan endo-1,3-beta-glucosidase" :
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase, endo-1,3(4)-beta-glucanase and endo-1,4-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-06-09
Efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2024-05-15
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2022-05-09
Safety and efficacy of a feed additive consisting of endo-1,3(4)-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-01-11
Safety and efficacy of a feed additive consisting of endo-1,4-beta xylanase, endo-1,4-beta-glucanase and xyloglucan-specific-endo-beta-1,4-glucanase produced by
EFSA journal. European Food Safety Authority
2022-12-19
4 publications dans cette catégorie
Publications dans "Glucan endo-1,3-beta-glucosidase" :
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase, endo-1,3(4)-beta-glucanase and endo-1,4-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-06-09
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with
EFSA journal. European Food Safety Authority
2022-05-09
Safety and efficacy of a feed additive consisting of endo-1,3(4)-beta-glucanase produced by
EFSA journal. European Food Safety Authority
2023-01-11
Safety and efficacy of a feed additive consisting of endo-1,4-beta xylanase, endo-1,4-beta-glucanase and xyloglucan-specific-endo-beta-1,4-glucanase produced by
EFSA journal. European Food Safety Authority
2022-12-19
4 publications dans cette catégorie
Affiliations :
Division of Infectious Diseases, Department of Health Sciences (DISSAL), University of Genova, Genova, Italy; IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Publications dans "Glucan endo-1,3-beta-glucosidase" :
Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the efficacy of ROVABIO® A...
The serum (1,3)-beta-d-glucan (BDG) assay gives quicker results and has higher sensitivity than blood cultures, therefore it is advised for early diagnosis of invasive candidemia and/or discontinuatio...
C. albicans, C. parapsilosis, and C. auris strains were collected from blood cultures of patients who had a concurrent (-1 to +72 hours) serum BDG test (Fungitell assay). Supernatants of all strains w...
Twenty-two C. auris, fourteen C. albicans, and ten C. parapsilosis strains were included. The median BDG levels in supernatants were 463 pg/mL (IQR 379-648) for C. auris, 1080 pg/mL (IQR 830-1276) for...
In our centre C. auris and C. parapsilosis strains have lower BDG content as compared to C. albicans, with significant impact on serum BDG performance for the diagnosis of candidemia....
The glycoside hydrolase family 55 (GH55) includes inverting exo-β-1,3-glucosidases and endo-β-1,3-glucanases, acting on laminarin, which is a β1-3/1-6-glucan consisting of a β1-3/1-6-linked main chain...
Endo-β-1,3-glucanase is a glycoside hydrolase (GH) that plays an essential role in the mineralization of β-glucan polysaccharides. In this study, the novel gene encoding an extracellular, non-modular ...
Two strains of neutrophilic haloaloarchaea were selectively enriched from hypersaline lakes in southwestern Siberia using β-1,3-glucans as a substrate. The strains were nearly identical in their pheno...
In this study, we conducted an in-depth analysis to characterize potential...
Use of curldlan, an insoluble β-1,3-glucan, as an enrichment substrate under aerobic conditions resulted in the selection from hypersaline soda lakes of a single natronarchaeon, strain AArc-curdl1. Th...
The additive role of non-culture-based methods for the diagnosis of candidemia remains unknown. We evaluated 2 clinical practices followed in our hospitals for the diagnosis of candidemia, namely prac...
To determine whether a decrease in serum (1,3)-β-D-glucan (BDG) was associated with reduced mortality and to investigate the performance of BDG downslope in predicting clinical outcome in invasive can...
Observational cohort study in ICU patients over a ten-year period (2012-2022) in Italy. Proven invasive candidiasis with at least 2 BDG determinations were considered....
In the study population of 103 patients (age 47 [35-62] years, SAPS II score 67 [52-77]) 68 bloodstream and 35 intrabdominal infections were recorded. Serial measurements showed that in 54 patients BD...
A decrease in serum BDG was associated with reduced mortality and a steep downslope predicted survival with high specificity in invasive candidiasis....
1,3-β-Glucan serves as the primary component of the fungal cell wall and is produced by 1,3-β-glucan synthase located in the plasma membrane. This synthase is a molecular target for antifungal drugs s...